DNA RNA and Cells

18 Mar 2010 Antisoma initiates phase IIb trial of AS1411 in acute myeloid leukaemia
17 Mar 2010 TiGenix reports on regulatory path for ChondroCelect in the US
16 Mar 2010 Tekmira and Pfizer Initiate New Research Collaboration
15 Mar 2010 Mipomersen Phase 3 Study in HoFH Patients Featured in The Lancet
15 Mar 2010 Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
15 Mar 2010 Alnylam and Collaborators Present New Pre-Clinical Research on RNAi Therapeutics Targeting PCSK9
12 Mar 2010 FDA Allows IND for Bio-Path Holdings' Liposomal Grb-2
11 Mar 2010 Pharmaxis completes phase II clinical study with ASM8 in asthma patients
10 Mar 2010 TRANSGENE SIGNS AN EXCLUSIVE OPTION AGREEMENT FOR THE DEVELOPMENT AND COMMERCIALISATION OF ITS IMMUNOTHERAPY PRODUCT TG4010
10 Mar 2010 Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
09 Mar 2010 Ark withdraws Cerepro MAA after SAG-O requests further trial before approval
09 Mar 2010 Aastrom Announces Treatment of Final Patient in IMPACT-DCM Surgical Clinical Trial
08 Mar 2010 Isis Earns $6 Million Milestone Payment From Bristol-Myers Squibb for BMS-PCSK9Rx
05 Mar 2010 ISIS Initiates Phase 1 Clinical Trial of ISIS-SOD1Rx in Patients With ALS
05 Mar 2010 MOLOGEN AG receives approval for clinical study with cancer drug MGN1703
04 Mar 2010 Argos Therapeutics Publishes Positive Immune Response, Safety and Manufacturing Data for its Arcelis HIV Program in Clinical Immunology
03 Mar 2010 New Research Reveals Mechanism By Which TNFerade(TM) Suppresses Metastases
03 Mar 2010 Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies
02 Mar 2010 Pluristem Therapeutics Receives DSMB Approval to Advance to Final Dose Level With PLX-PAD
01 Mar 2010 Quark Announces Dosing of the First Patient in Phase I Clinical Trial of its Ocular Neuroprotective Agent, QPI-1007
25 Feb 2010 The European Medicines Agency is in Overall Agreement with OncoGenex Pharmaceuticals' Development Plan for OGX-011 in Patients with Metastatic Castrate-Resistant Prostate Cancer
25 Feb 2010 Regulus Therapeutics and GlaxoSmithKline Establish New Collaboration to Develop and Commercialize microRNA Therapeutics Targeting miR-122
24 Feb 2010 Aastrom Reports Interim Results From Critical Limb Ischemia Trial
24 Feb 2010 New Study Demonstrates Effectiveness of Prochymal as a Rescue Therapy for Pediatric Patients with Severe Graft vs. Host Disease
23 Feb 2010 Idera Pharmaceuticals Presents Mechanism of Action Data on IMO-3100, a Novel Toll-like Receptor Antagonist for Autoimmune Diseases, at Keystone Symposium

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top